Filtered By:
Condition: Eczema
This page shows you your search results in order of date. This is page number 10.
Order by Relevance | Date
Total 2491 results found since Jan 2013.
Do Atopic Dermatitis Patient-Reported Outcomes Correlate With Validated Investigator Global Assessment? Insights From TARGET-AD Registry
CONCLUSIONS: In this real-world study of patients with AD, greater clinician-reported disease severity is positively correlated with higher patient-reported disease severity and lower QoL. J Drugs Dermatol. 2023;22(4): doi:10.36849/JDD.7473 Access Supplementary Material here Citation: Guttman-Yassky E, Bar J, Rothenberg Lausell C, et al. Do atopic dermatitis patient-reported outcomes correlate with validated investigator global assessment? Insights from TARGET-AD registry. J Drugs Dermatol. 2023;22(4):344-355. doi:10.36849/JDD.7473.PMID:37026893 | DOI:10.36849/JDD.7473
Source: Journal of Drugs in Dermatology - April 7, 2023 Category: Dermatology Authors: Emma Guttman-Yassky Jonathan Bar Camille Lausell Lawrence Eichenfield Ayman Grada Katrina Abuabara M Chapman Brian Calimlim Colleen Wegzyn Amy Gamelli Whitney Krueger Breda Munoz Keith Knapp Rachel Faller Julie Crawford Jonathan Silverberg Source Type: research
Association between maternal gestational diabetes and allergic diseases in offspring: a birth cohort study
CONCLUSIONS: Maternal GDM was adversely associated with early-life allergic diseases, especially eczema. We were the first to identify OGTT-2 h glucose to be more sensitive in inducing allergy risk and that dietary PUFAs might modify the associations.PMID:37029331 | DOI:10.1007/s12519-023-00710-0
Source: World Journal of Pediatrics : WJP - April 7, 2023 Category: Pediatrics Authors: Yu-Jing Chen Li-Zi Lin Zhao-Yan Liu Xin Wang Shamshad Karatela Yu-Xuan Wang Shan-Shan Peng Bi-Bo Jiang Xiao-Xu Li Nan Liu Jin Jing Li Cai Source Type: research
Do Atopic Dermatitis Patient-Reported Outcomes Correlate With Validated Investigator Global Assessment? Insights From TARGET-AD Registry
CONCLUSIONS: In this real-world study of patients with AD, greater clinician-reported disease severity is positively correlated with higher patient-reported disease severity and lower QoL. J Drugs Dermatol. 2023;22(4): doi:10.36849/JDD.7473 Access Supplementary Material here Citation: Guttman-Yassky E, Bar J, Rothenberg Lausell C, et al. Do atopic dermatitis patient-reported outcomes correlate with validated investigator global assessment? Insights from TARGET-AD registry. J Drugs Dermatol. 2023;22(4):344-355. doi:10.36849/JDD.7473.PMID:37026893 | DOI:10.36849/JDD.7473
Source: Journal of Drugs in Dermatology - April 7, 2023 Category: Dermatology Authors: Emma Guttman-Yassky Jonathan Bar Camille Lausell Lawrence Eichenfield Ayman Grada Katrina Abuabara M Chapman Brian Calimlim Colleen Wegzyn Amy Gamelli Whitney Krueger Breda Munoz Keith Knapp Rachel Faller Julie Crawford Jonathan Silverberg Source Type: research
Association between maternal gestational diabetes and allergic diseases in offspring: a birth cohort study
CONCLUSIONS: Maternal GDM was adversely associated with early-life allergic diseases, especially eczema. We were the first to identify OGTT-2 h glucose to be more sensitive in inducing allergy risk and that dietary PUFAs might modify the associations.PMID:37029331 | DOI:10.1007/s12519-023-00710-0
Source: World Journal of Pediatrics : WJP - April 7, 2023 Category: Pediatrics Authors: Yu-Jing Chen Li-Zi Lin Zhao-Yan Liu Xin Wang Shamshad Karatela Yu-Xuan Wang Shan-Shan Peng Bi-Bo Jiang Xiao-Xu Li Nan Liu Jin Jing Li Cai Source Type: research
Do Atopic Dermatitis Patient-Reported Outcomes Correlate With Validated Investigator Global Assessment? Insights From TARGET-AD Registry
CONCLUSIONS: In this real-world study of patients with AD, greater clinician-reported disease severity is positively correlated with higher patient-reported disease severity and lower QoL. J Drugs Dermatol. 2023;22(4): doi:10.36849/JDD.7473 Access Supplementary Material here Citation: Guttman-Yassky E, Bar J, Rothenberg Lausell C, et al. Do atopic dermatitis patient-reported outcomes correlate with validated investigator global assessment? Insights from TARGET-AD registry. J Drugs Dermatol. 2023;22(4):344-355. doi:10.36849/JDD.7473.PMID:37026893 | DOI:10.36849/JDD.7473
Source: Journal of Drugs in Dermatology - April 7, 2023 Category: Dermatology Authors: Emma Guttman-Yassky Jonathan Bar Camille Lausell Lawrence Eichenfield Ayman Grada Katrina Abuabara M Chapman Brian Calimlim Colleen Wegzyn Amy Gamelli Whitney Krueger Breda Munoz Keith Knapp Rachel Faller Julie Crawford Jonathan Silverberg Source Type: research
